4/3/19 21:00 | 4/1/19 | NITE | Nightstar Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Fellows David A | MA | DO | CEO | S | -236 | 25.31 | 0 | -9 | -1 | 617 | D | | | | | | | | | | | | | | |
3/21/19 21:01 | 1/7/19 | NITE | Nightstar Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Fellows David A | MA | DO | CEO | S.a | -113 | 12.98 | 0 | -9 | -1 | 626 | D | | | | | | | | | | | | | | |
1/9/19 21:10 | 1/7/19 | NITE | Nightstar Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Fellows David A | MA | DO | CEO | S | -113 | 12.98 | 0 | -9 | -1 | 631 | D | | | | | | | | | | | | | | |
11/3/03 19:53 | 10/30/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Fellows David A | CA | O | CVP,P,Eu | M.d | 280 | 13.01 | 33 | 22 | | 21 | D | -18 | 43 | 31 | -1 | -9 | -4 | -2 | -1 | -2 | 10 | 25 | 20 | -9 | -30 |
11/3/03 19:53 | 10/30/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Fellows David A | CA | O | CVP,P,Eu | S.d | -1,637 | 76.06 | 33 | -22 | -50 | 21 | D | -18 | 43 | 31 | -1 | -9 | -4 | -2 | -1 | -2 | 10 | 25 | 20 | -9 | -30 |
10/29/03 18:13 | 10/28/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Fellows David A | CA | O | CVP,P,Eu | M.d | 260 | 13.01 | 28 | 20 | 999% | 21 | D | -21 | 49 | 36 | -1 | -12 | -4 | -3 | -2 | 0 | 0 | 23 | 22 | -4 | -26 |
10/29/03 18:13 | 10/28/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Fellows David A | CA | O | CVP,P,Eu | S.d | -1,521 | 76.06 | 28 | -20 | -49 | 21 | D | -21 | 49 | 36 | -1 | -12 | -4 | -3 | -2 | 0 | 0 | 23 | 22 | -4 | -26 |
10/28/03 18:50 | 10/24/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Fellows David A | CA | O | CVP,P,Eu | M.d | 192 | 13.01 | 26 | 15 | 231 | 21 | D | -16 | 57 | 40 | 1 | -9 | -3 | -3 | 1 | -3 | -2 | 18 | 18 | 7 | -32 |
10/28/03 18:50 | 10/24/03 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Fellows David A | CA | O | CVP,P,Eu | S.d | -1,128 | 76.54 | 26 | -15 | -41 | 21 | D | -16 | 57 | 40 | 1 | -9 | -3 | -3 | 1 | -3 | -2 | 18 | 18 | 7 | -32 |